z-logo
open-access-imgOpen Access
Linagliptin—Role in the Reversal of A β ‐Mediated Impairment of Insulin Signaling and Reduced Neurotoxicity in AD Pathogenesis: Some Considerations
Author(s) -
Srinivas Nuggehally R.
Publication year - 2015
Publication title -
cns neuroscience and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 69
eISSN - 1755-5949
pISSN - 1755-5930
DOI - 10.1111/cns.12475
Subject(s) - linagliptin , saxagliptin , incretin , vildagliptin , dipeptidyl peptidase 4 , pharmacology , insulin , medicine , sitagliptin , insulin receptor , diabetes mellitus , metformin , type 2 diabetes , endocrinology , insulin resistance

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom